ONCOLYTICS BIOTECH INC — Director's Dealing 2026

Jan 2, 2026

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ONCOLYTICS BIOTECH INC (ONCY)
CIK: 0001129928
Period of Report: 2026-01-01

Reporting Person: Brown Deborah Margaret (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	84851	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$5.42	2027-11-07	Common Shares (5263)		Direct
Stock Option	$3.40	2026-03-08	Common Shares (30000)		Direct
Stock Option	$1.14	2026-06-16	Common Shares (30000)		Direct
Stock Option	$2.76	2028-08-15	Common Shares (30000)		Direct
Stock Option	$1.13	2029-12-18	Common Shares (30000)		Direct
Stock Option	$1.08	2030-08-15	Common Shares (120000)		Direct
Stock Option	$1.08	2030-08-15	Common Shares (30000)		Direct

Footnotes

F1: The stock option is fully vested and exercisable.

F2: The exercise price is listed in Canadian dollars.

F3: The stock option vests in three equal annual installments beginning on August 15, 2026.

F4: The stock option vests in full on August 15, 2026.